Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2008
10/16/2008WO2008054561A3 Proteins, nucleic acids encoding the same and associated methods of use
10/16/2008WO2008028946A3 Human binding molecules capable of neutralizing influenza virus h5n1 and uses thereof
10/16/2008WO2008027244A3 Separation of platelets from fluid suspensions
10/16/2008WO2008019351A3 Compositions and their uses directed to diacylglycerol acyltransferase 1
10/16/2008WO2008011107A3 Antagonists of protease activated receptor-1 (par1)
10/16/2008WO2008005847A3 Method of producing factor viii proteins by recombinant methods
10/16/2008WO2007149182A3 Differentiation and enrichment of islet-like cells from human pluripotent stem cells
10/16/2008WO2007143117A3 Differentiation of primate pluripotent cells to hepatocyte-lineage cells
10/16/2008WO2007139929A3 Methods for culture and production of single cell populations of human embryonic stem cells
10/16/2008WO2007123777A3 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
10/16/2008WO2007120911A3 Cellular labeling and quantification for nuclear magnetic resonance techniques
10/16/2008WO2007117682A3 Mature dendritic cell compositions and methods for culturing same
10/16/2008WO2007115230A3 A strategy for homo- or hetero-dimerization of various proteins in solutions and in cells
10/16/2008WO2007102872A3 Compositions and methods related to controlled gene expression using viral vectors
10/16/2008WO2007100692A3 Method of generating human retinal progenitors from embryonic stem cells
10/16/2008WO2007094924A3 Human telomerase reverse transcriptase peptides
10/16/2008WO2007087576A3 Compositions and methods for the identification and treatment of immune-mediated inflammatory diseases
10/16/2008WO2006086746A3 Homogeneous neural precursor cells
10/16/2008WO2005032463A3 Educated nkt cells and their uses in the treatment of immune-related disorders
10/16/2008US20080256670 AtRSp gene promoters
10/16/2008US20080256666 Using increased ribulose 1,5-bisphosphate carboxylase/oxygenase (Rubisco) activity as reporter function indicating regenerated photosynthetic and production processes in plants
10/16/2008US20080256659 Eg8798 and Eg9703 Polynucleotides and Uses Thereof
10/16/2008US20080256658 Petunia Mutant Allele
10/16/2008US20080256649 Insect hydrolase for use as tool in identifying modulators which prevent mosquito propagation; genetic detection of resistance to organophosphorus and/or carbamates pesticides
10/16/2008US20080255677 Surfaces differentially adhesive to bacteria and eukaryotic cells
10/16/2008US20080255253 Extraneous fetal urogenital sinus or tissue from under the skin
10/16/2008US20080255213 4R)-2-(benzo[d][1,3]dioxol-5-yl)-N-decylthiazolidine-4-carboxamide; prostate cancer, breast cancer, ovarian cancer, skin cancer
10/16/2008US20080255210 1-Benzyl-3-[3-(3,5-dimethyl-phenyl)-5,5-dimethyl-[1,2,4]oxadiazol-4-yl]-urea; nuclear receptor-based inducible gene expression system
10/16/2008US20080255194 1-(4-(3-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)propoxy)-3-methoxy-d3-phenyl)ethanone substituted with deuterium ions; antipsycholtic agent
10/16/2008US20080255163 Compounds such as 2-piperidino-6-methyl-5-oxo-5,6-dihydro-(7H) pyrrole-[3,4-d]pyrimidine maleate (MS-818); nervous system, brain, and neurodegenerative disorders; Parkinson's, Alzheimer's, and Huntington's disease
10/16/2008US20080255155 Inhibit protein tyrosine kinase; treating cell proliferative diseases and conditions; N-(6-(2-Fluoro-4-(4,4,4-trifluoro-3-(4-fluorophenylamino)butanamido)phenoxy)pyrimidin-4-yl)pyrrolidine-1-carboxamide
10/16/2008US20080255099 Use of Diketodithiopiperazine Antibiotics for the Preparation of Antiangiogenic Pharmaceutical Compositions
10/16/2008US20080255070 Bisphosphonate Compounds and Methods with Enhanced Potency for Multiple Targets including FPPS, GGPPS, AND DPPS
10/16/2008US20080255064 Biological assay; experimental reporter expression vector has cholecystokinin promoter upregulating agent operably linked to experimental Renilla luciferase reporter gene; separately detectable; co-transform experimental vector and control vector in pancreatic islet host cells; increase plasma insulin
10/16/2008US20080255062 Axon regeneration from adult sensory neurons
10/16/2008US20080255059 Regulators of the hedgehog pathway, compositions and uses related thereto
10/16/2008US20080255040 Polypeptide with amino acid sequences including exogenous glycosylated sequences; libraries
10/16/2008US20080254989 Controllers; polynucleotides isolated from ribosomal protein ; chaperone proteins; gene expression of transgene
10/16/2008US20080254551 Using support immobilized immunmoglobulin fusions as separation and classification tools in screening fluids for preferential analytes
10/16/2008US20080254540 METHODS OF GENETICALLY ENCODING UNNATURAL AMINO ACIDS IN EUKARYOTIC CELLS USING ORTHOGONAL tRNA/SYNTHETASE PAIRS
10/16/2008US20080254538 Treatment of Neurological Deficits in the Striatum or Substanta Nigra Pars Compacta
10/16/2008US20080254537 Using activated dendritic cell to induce thymocyte response directed towards tumor targets; tissue engineering; tissue targeted therapy
10/16/2008US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE
10/16/2008US20080254513 Cell Culture Medium
10/16/2008US20080254510 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto
10/16/2008US20080254506 Claudin polypeptides
10/16/2008US20080254488 Cancer Test
10/16/2008US20080254475 Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of a nematode gene
10/16/2008US20080254460 Using immunoaffinity chromatography to isolate cells, form maternal blood which express CD34 antigen; sexing developing fetus
10/16/2008US20080254440 Anti-Sars Virus Antibody, Hybridoma Producing the Antibody and Immunoassay Reagent Using the Antibody
10/16/2008US20080254439 Plant Extract and Use Thereof as a Cryoprotective Agent
10/16/2008US20080254195 Isolated nucleic acid fragments and recombinant constructs; plant cells, transgenic seeds, progeny plants
10/16/2008US20080254192 Delta-8 desaturases and their use in making polyunsaturated fatty acids
10/16/2008US20080254191 Multizymes and their use in making polyunsaturated fatty acids
10/16/2008US20080254093 Compositions and minimally invasive methods for treating dysfunction of cardiac muscle
10/16/2008US20080254092 Promoting wound healing and tissue regeneration; inhibiting scarring; degenerative diseases
10/16/2008US20080254090 Porcine Islets Cultured With Porcine Sertoli Cells For Xenotransplantation
10/16/2008US20080254067 Process for the Production of an Influenza Vaccine
10/16/2008US20080254064 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
10/16/2008US20080254059 Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby
10/16/2008US20080254051 Maintaining cytotoxic lymphocyte response to cell proliferation and/or viral infection via re-adminintering tumor antigen and/or viral particles; immunotherapy
10/16/2008US20080254048 He4 monoclonal antibodies and methods for their use
10/16/2008US20080254047 Activation of Human Antigen-Presenting Cells Through CLEC-6
10/16/2008US20080254046 Method for the Delivery of Exogenous Antigens into the Mhc Class I Presentation Pathway of Cells
10/16/2008US20080254045 Therapeutic mixture comprising a non-specific cluster of differentiation-1 (CD1d) complex which comprises beta 2-microglobulin and binds ceramide-like glycolipid antigens for use in treatment of autoimmune disorders
10/16/2008US20080254035 Expression vector comprising lipocalin gene sequences for use in prevention and treatment of cell proliferative, inflammatory, autoimmune and cardiovascular disorders
10/16/2008US20080254034 Microbial membrane protein for use in diagnosis, prevention and treatment of gramnegative bacterial infection
10/16/2008US20080254033 Pharmaceutical Compositions Containing Antagonists to Lrp4, Lrp8 or Megalin for Treatment of Diseases
10/16/2008US20080254032 Colony stimulating bfcator specific monoclonal antibody for use in diagnosis, prevention and treatment of infcetion, cell proliferative, inflammatory, autoimmune, arthritic, skin, respiratory and nervous system disorders
10/16/2008US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders
10/16/2008US20080254027 Optimized CD5 antibodies and methods of using the same
10/16/2008US20080254026 Tumor necrosis factor specific immunoglobulin for use in classification, treatment and prevention of autoimmune, liver, arthritic, skin and cell proliferative disorders
10/16/2008US20080254024 Anti-ephb2 antibodies and methods using same
10/16/2008US20080254021 Tie1-binding ligands
10/16/2008US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue
10/16/2008US20080254007 Human Mesenchymal Progenitor Cell
10/16/2008US20080254004 Homogeneous Neural Precursor Cells
10/16/2008US20080254003 Differentiation of Human Embryonic Stem Cells and Cardiomyocytes and Cardiomyocyte Progenitors Derived Therefrom
10/16/2008US20080254002 Bone Marrow Derived Oct3/4+ Stem Cells
10/16/2008US20080254001 Novel bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways
10/16/2008US20080253999 Methods For Differentiating Stem Cells and Uses Thereof in the Treatment of Dental Conditions
10/16/2008US20080253977 Nucleic acid encoding plant lipase polypeptide isolated from Deschampsia antarctica; host cell from Pichia containing expression vector; genetic engineering; waste water cleaning; sunscreen agents
10/16/2008US20080253962 Irta-4 Antibodies and Their Uses
10/16/2008CA2684792A1 Nucleic acids and libraries
10/16/2008CA2683143A1 Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
10/16/2008CA2683060A1 Patient-specific stem cell lines derived from human parthenogenetic blastocysts
10/16/2008CA2682950A1 Methods for transforming eukaryotic algae
10/16/2008CA2682317A1 Enrichment of tissue-derived adult stem cells based on retained extracellular matrix material
10/16/2008CA2681461A1 Improved bioreactor surfaces
10/16/2008CA2681145A1 Delta-8 desaturases and their use in making polyunsaturated fatty acids
10/15/2008EP1980617A1 Improved expression of HIV polypeptides and production of virus-like particles
10/15/2008EP1980615A1 Polypeptide having affinity for envelope virus constituent and use thereof in transferring substance into cell
10/15/2008EP1980613A1 Method of maintaining the function of liver tissue cells over long time
10/15/2008EP1980573A2 Isolated dendritic cell membrane protein genes
10/15/2008EP1980268A2 Vaccination methods against avian influenza virus
10/15/2008EP1979514A1 Polymer backbone for producing artificial tissue
10/15/2008EP1979471A1 Enrichment of cells
10/15/2008EP1979470A2 Cell culture
10/15/2008EP1979466A2 High-throughput cell-based assays fabricated with integrated silicon and cell culture technologies
10/15/2008EP1979050A2 Treatment of peripheral vascular disease using postpartum-derived cells
1 ... 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 ... 1827